Litcius/Paper detail

Low Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Pregnant and Postpartum Patients With Universal Screening in Seattle, Washington

Sylvia M. LaCourse, Alisa Kachikis, Michela Blain, LaVone E. Simmons, James A. Mays, Amber D Pattison, Carol C Salerno, Stephen A. McCartney, Nicole M. Kretzer, Rebecca Resnick, Rosemary Shay, Leah M. Savitsky, Anna Curtin, Emily M. Huebner, Kimberly Kelly, Shani Delaney, Carlos Delgado, Adrienne Schippers, Jeff Munson, Paul S. Pottinger, Seth A. Cohen, Santiago Neme, Lori Bourassa, Andrew Bryan, Alexander L. Greninger, Keith R. Jerome, Alison C. Roxby, Erica M. Lokken, Edith Cheng, Kristina M. Adams Waldorf, Jane Hitti

2020Clinical Infectious Diseases43 citationsDOIOpen Access PDF

Abstract

We found low prevalence of SARS-CoV-2 (2.7% [5/188]) among pregnant and postpartum patients with universal testing. Prevalence among symptomatic patients was similar under initial targeted screening (22.2% [4/18]) and universal approaches (19.1% [8/42]). Among 170 asymptomatic patients, 2 were positive or inconclusive, respectively; repeat testing at 24 hours was negative.

Topics & Concepts

MedicineAsymptomaticCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Respiratory systemPregnancyCoronavirusPediatrics2019-20 coronavirus outbreakObstetricsInternal medicineVirologyDiseaseOutbreakInfectious disease (medical specialty)BiologyGeneticsCOVID-19 Impact on ReproductionCOVID-19 and healthcare impactsPregnancy and Medication Impact